SCHEMBL2698949

SCHEMBL2698949

COC(=O)c1sc(-c2ccccc2Cl)c(Br)c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM6 O15303 1/20 0.43
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41
TUBA4A P68366 1/20 0.41
TUBB4B P68371 1/20 0.41
TUBB3 Q13509 1/20 0.41
TUBB2A Q13885 1/20 0.41
TUBB8 Q3ZCM7 1/20 0.41
TUBA3E Q6PEY2 1/20 0.41
TUBA1A Q71U36 1/20 0.41
TUBA1C Q9BQE3 1/20 0.41
TUBB6 Q9BUF5 1/20 0.41
TUBB2B Q9BVA1 1/20 0.41
TUBB1 Q9H4B7 1/20 0.41
LMNA P02545 4/20 0.41
TSHR P16473 2/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL476338 0.88 PTPN1 (0.47) GRM6TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2696570 0.85 ALPL (0.46) PTPN1NPC1MAPTRAB9AKDM4E
SCHEMBL12482976 0.83 GRM6 (0.49) GRM6LMNATSHRGAAHTT
SCHEMBL2682815 0.80 TP53 (0.48) GRM6TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL476185 0.73 PTPN1 (0.44) PTPN1MAPTKDM4EHPGDALDH1A1
SCHEMBL2683604 0.71 SLC6A3 (0.49) GRM6LMNATSHRGAAHTT
SCHEMBL2682770 0.70 MAPT (0.48) LMNATSHRGAAPTPN1NPC1
SCHEMBL1529538 0.69 KMT2A (0.41) LMNATSHRGAAHTTPTPN1
SCHEMBL31398801 0.69 MAPT (0.47) LMNATSHRGAAPTPN1MAPT
SCHEMBL9750566 0.69 CDC7 (0.51) LMNATSHRGAAHTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8486971-B2 Derivatives of 3-alkoxy-4,5-diarylthiophene-2-carboxamide, preparation thereof, and therapeutic use thereof SANOFI (FR) 2013-07-16 US disclosed
US-20120115906-A1 DERIVATIVES OF 3-ALKOXY-4,5-DIARYLTHIOPHENE-2-CARBOXAMIDE, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115906-A1 DERIVATIVES OF 3-ALKOXY-4,5-DIARYLTHIOPHENE-2-CARBOXAMIDE, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF HRH4, HCRTR1, NR3C1 GRM6 141/4885TUBB4A 1744/4885TUBB 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.